HUNDREDS of women with ovarian cancer will benefit from a new NHS drug in the biggest breakthrough against the disease for ...

The most common cholesterol drug around might help protect cancer patients from "chemo brain." Statins appeared to protect breast and lymphoma cancer patients' brain function for up to two years after ...

In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and ...

Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized ...

A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent ...

Oct 24 (Reuters) - A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of researchers reported at a major European oncology ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

Injections and infusions are a common way to receive chemotherapy. Both methods deliver cancer-treating medications directly into the bloodstream. Chemotherapy is a common cancer treatment that uses ...

In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of chemotherapy in animal experiments. Instead of attacking cancer directly, ...

Enhertu isn’t a typical chemotherapy or immunotherapy drug but rather a combination of chemotherapy and targeted therapy, known as an antibody-drug conjugate. Enhertu works by using an antibody to ...